Global Artificial Heart Lung Machines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Artificial Heart Lung Machines market size was valued at US$ 298 million in 2024 and is forecast to a readjusted size of USD 386 million by 2031 with a CAGR of 3.8% during review period.

Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.

Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.

This report is a detailed and comprehensive analysis for global Artificial Heart Lung Machines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Artificial Heart Lung Machines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031

Global Artificial Heart Lung Machines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031

Global Artificial Heart Lung Machines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031

Global Artificial Heart Lung Machines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Artificial Heart Lung Machines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Artificial Heart Lung Machines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Artificial Heart Lung Machines market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Single Roller Pump HLM
Double Roller Pump HLM

Market segment by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others

Major players covered
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Artificial Heart Lung Machines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Artificial Heart Lung Machines, with price, sales quantity, revenue, and global market share of Artificial Heart Lung Machines from 2020 to 2025.

Chapter 3, the Artificial Heart Lung Machines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Artificial Heart Lung Machines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Artificial Heart Lung Machines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Heart Lung Machines.

Chapter 14 and 15, to describe Artificial Heart Lung Machines sales channel, distributors, customers, research findings and conclusion.